Financings
Treatment.com AI arranges $3-million private placement

AIDR · Price
Executive Summary
- Treatment.com AI Inc. announced a non-brokered private placement of up to C$3 million in special warrants and units.
- The offering is priced at 50 cents per special warrant or unit, with each unit comprising one common share and one common share purchase warrant exercisable at 75 cents per share.
- Proceeds are intended for working capital, with an expected closing date on or before August 18, 2025.
Key Details
- Offering Size: Up to C$3 million.
- Instrument Structure:
- Special Warrants: Priced at 50 cents each. These automatically convert into one unit (one common share + one warrant) for no additional consideration.
- Units: Priced at 50 cents each. Each unit consists of one common share and one common share purchase warrant.
- Warrant Terms: Each warrant entitles the holder to acquire one share at an exercise price of 75 cents per share for a period of 12 months following issuance.
- Conversion Timeline: Special warrants convert into units on the earlier of: (i) the third business day after filing a prospectus supplement to a short form base shelf prospectus, or (ii) four months and one day after the issue date.
- Prospectus Filing: The company intends to file the prospectus supplement within 60 days of the closing of the offering.
- Finder’s Fees: The company may pay a finder’s fee of up to 8% of gross proceeds and issue non-transferable broker warrants equal to up to 8% of the special warrants/units sold. Broker warrants have an exercise price of 75 cents per share and a 12-month term.
- Use of Proceeds: Working capital purposes.
- Closing Date: Expected on or before August 18, 2025.
- Regulatory Conditions: Subject to necessary approvals, including the Canadian Securities Exchange.
- Hold Periods:
- Special warrants, broker warrants, and units issued at closing are subject to a statutory hold period of four months plus one day.
- Units and underlying securities issuable upon conversion of special warrants are subject to the same statutory hold period prior to the filing of the prospectus supplement.
- Minimum Subscription: The offering is not subject to a minimum aggregate amount of subscriptions.
More from Treatment.com AI Inc
Jun 30, 2026 · 08:00